Other Viruses Citation List:
October 15 - October 28, 2010
Human Cytomegalovirus (HCMV)
1. 2-Azetidinone - A new profile of various pharmacological activities. Mehta, P.D., N.P. Sengar, and A.K. Pathak. European Journal of Medicinal Chemistry, 2010. [Epub ahead of print]; PMID[20970895].
[Pubmed]. OV_1015-102810.
Hepatitis B virus
2. Antiviral activity of 5'-O-carbonate-2',3'-dideoxy-3'-thiacytidine prodrugs against hepatitis B virus in HepG2 2.2.15 cells. Gagey, D., S. Ravetti, E.F. Castro, M.S. Gualdesi, M.C. Brinon, R.H. Campos, and L.V. Cavallaro,. International Journal of Antimicrobial Agents, 2010. [Epub ahead of print]; PMID[20947311].
[Pubmed]. OV_1015-102810.
Hepatitis C virus
3. A new natural alpha-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV. Yan, R., Z. Zhao, Y. He, L. Wu, D. Cai, W. Hong, Y. Wu, Z. Cao, C. Zheng, and W. Li. Peptides, 2010. [Epub ahead of print]; PMID[20950663].
[Pubmed]. OV_1015-102810.
Citations from the ISI Web of Knowledge Listings for O.I.
4. Hepatitis C Virus NS3 Protease Inhibitors based on 2(1H)-Pyrazinones. Belfrage, A.K., J. Gising, P. Ortqvist, U.H. Danielson, M. Larhed, and A. Sandstrom. Journal of Peptide Science, 2010. 16: p. 95-95; PMID[ISI:000281610800230].
[WOS]. OV_1015-102810.
5. Cyclophilin Inhibitors as a Novel HCV Therapy. Tang, H.L. Viruses-Basel, 2010. 2(8): p. 1621-1634; PMID[ISI:000282477000009].
[WOS]. OV_1015-102810.
6. Tricyclic 2 '-C-Modified Nucleosides as Potential Anti-HCV Therapeutics. Wauchope, O.R., M.J. Tomney, J.L. Pepper, B.E. Korba, and K.L. Seley-Radtke. Organic Letters, 2010. 12(20): p. 4466-4469; PMID[ISI:000282604700009].
[WOS]. OV_1015-102810.